Lineage Cell Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 101-125 of 1,000 matching filings.

Per page
25
Current page
5
EFFECT File 333-277758

EFFECT filing

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277758

424B5

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-12830

ARS

Filing date
29 Apr 2024
Reporting date
29 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12830

DEFA14A

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-12830

DEF 14A

Filing date
29 Apr 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254167

424B5 filing

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-277758

S-3 filing

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2024
Reporting date
11 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Feb 2024
Reporting date
11 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Feb 2024
Reporting date
08 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Feb 2024
Reporting date
06 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-42290

SC 13D/A filing

Filing date
08 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254167

424B5 filing

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254167

424B5 filing

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .